Literature DB >> 34926230

Tall cell carcinoma with reversed polarity: case report with gene sequencing and literature review.

Yufan Wei1,2, Liming Ding3, Xin Song4, Xia Tian4, Ningning Min1,2, Qingyu Guan1,2, Xiru Li2, Mei Liu4.   

Abstract

Tall cell carcinoma with reversed polarity (TCCRP) is an extremely rare type of invasive breast cancer with only 17 literatures and 75 cases reported. Knowledge on TCCRP is still scanty. The present study reported 2 cases of TCCRP, analyzed their clinicopathological characteristics, and used whole exome sequencing to perform genetic testing. Both two cases were proved to have typical clinicopathological manifestations (solid and papillary architectures lined by tall columnar cells with nuclei displaying "reverse polarization") and hotspot mutations (IDH2 and PIK3CA mutations) of TCCRP. Furthermore, positive expression of TTF-1 was found in a small number of tumor cells nuclei and normal ductal epithelial cells, while the negative rate of TTF-1 in previous case reports was 100%. Attention should be paid in core needle biopsy to avoid misdiagnosis. In addition, this article also reviewed all previous cases and demonstrated that the positive expression of calretinin might have an indicative significance for TCCRP, which could be used as one of the auxiliary diagnosis tools. The diagnosis of TCCRP requires comprehensive analysis of clinical pathology and genetic testing results. There is no clear treatment standard for TCCRP currently, further research should be reported to characterize and deeply investigate the diagnosis and treatment criteria of TCCRP. 2021 Gland Surgery. All rights reserved.

Entities:  

Keywords:  IDH2 mutation; Tall cell carcinoma with reversed polarity (TCCRP); breast cancer; case report; genetic testing

Year:  2021        PMID: 34926230      PMCID: PMC8637072          DOI: 10.21037/gs-21-591

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  20 in total

Review 1.  Changing the term "breast tumor resembling the tall cell variant of papillary thyroid carcinoma" to "tall cell variant of papillary breast carcinoma".

Authors:  Shahla Masood; Cindy Davis; Melanie J Kubik
Journal:  Adv Anat Pathol       Date:  2012-03       Impact factor: 3.875

2.  An additional case of breast tumor resembling the tall cell variant of papillary thyroid carcinoma.

Authors:  Renato Colella; Angela Guerriero; Michele Giansanti; Angelo Sidoni; Guido Bellezza
Journal:  Int J Surg Pathol       Date:  2014-05-26       Impact factor: 1.271

3.  Breast tumor resembling the tall cell variant of papillary thyroid carcinoma.

Authors:  Sing Yun Chang; David M Fleiszer; Benoît Mesurolle; Mona El Khoury; Atilla Omeroglu
Journal:  Breast J       Date:  2009-07-05       Impact factor: 2.431

4.  Breast tumor resembling the tall cell variant of papillary thyroid carcinoma: report of 5 cases.

Authors:  V Eusebi; S Damiani; I O Ellis; J G Azzopardi; J Rosai
Journal:  Am J Surg Pathol       Date:  2003-08       Impact factor: 6.394

5.  Papillary carcinoma of the breast lacks evidence of RET rearrangements despite morphological similarities to papillary thyroid carcinoma.

Authors:  Omar Hameed; Arie Perry; Ruma Banerjee; Xiaopei Zhu; John D Pfeifer
Journal:  Mod Pathol       Date:  2009-06-19       Impact factor: 7.842

6.  Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile.

Authors:  Carey A Eberle; Salvatore Piscuoglio; Emad A Rakha; Charlotte K Y Ng; Felipe C Geyer; Marcia Edelweiss; Rita A Sakr; Britta Weigelt; Jorge S Reis-Filho; Ian O Ellis
Journal:  Histopathology       Date:  2016-01-07       Impact factor: 5.087

7.  Tall cell carcinoma of the breast with reverse polarity: case report with gene sequencing and literature review.

Authors:  Xiaohui Zhang; Huanwen Wu; Zhe Wang; Yidong Zhou; Feng Mao; Yan Lin; Songjie Shen; Zhiyong Liang; Qiang Sun
Journal:  Gland Surg       Date:  2021-02

8.  Breast Tumor Resembling Tall Cell Variant of Papillary Thyroid Carcinoma: A Solid Papillary Neoplasm With Characteristic Immunohistochemical Profile and Few Recurrent Mutations.

Authors:  Rohit Bhargava; Anca V Florea; Manuela Pelmus; Miroslawa W Jones; Marguerite Bonaventura; Abigail Wald; Marina Nikiforova
Journal:  Am J Clin Pathol       Date:  2017-04-01       Impact factor: 2.493

9.  Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort.

Authors:  John R Lozada; Thais Basili; Fresia Pareja; Barbara Alemar; Arnaud Da Cruz Paula; Rodrigo Gularte-Merida; Dilip D Giri; Patricia Querzoli; Gabor Cserni; Emad A Rakha; Maria P Foschini; Jorge S Reis-Filho; Edi Brogi; Britta Weigelt; Felipe C Geyer
Journal:  Histopathology       Date:  2018-06-01       Impact factor: 7.778

10.  Tall Cell Carcinoma with Reverse Polarity of Breast: Report of a Case with Unique Morphologic and Molecular Features.

Authors:  Mohamed Jassim; Chennagiri S Premalata; Geeta Okaly; Chunduri Srinivas
Journal:  Turk Patoloji Derg       Date:  2021
View more
  1 in total

1.  Codon 172 in the IDH2 gene is a mutational hotspot in tall cell carcinoma with reversed polarity of the breast.

Authors:  Eiichi Sasaki; Katsuhiro Masago
Journal:  Gland Surg       Date:  2022-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.